• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avalyn Pharma Inc. - common stock (NQ:AVLN)

27.25 +2.14 (+8.52%)
Delayed Quote Updated: 4:00 PM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 286,745
Open 25.12
Bid (Size) 10.92 (200)
Ask (Size) 43.66 (200)
Prev. Close 25.11
Today's Range 25.10 - 27.57
52wk Range 22.24 - 40.17
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Avalyn Publishes Phase 1 Data Highlighting AP02’s Lung-Targeted Delivery and Encouraging Safety Profile
September 21, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors
September 16, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire

Performance

52-Week Range 32.2% below 52-week high
27.25
22.2452W Low 40.1752W High
1 Week 1.2% below 1-week high
22.241W Low 27.571W High

Avalyn Pharma Inc. - common stock (AVLN) traded between $22.24 and $40.17 over the past 52 weeks and last traded at $27.25, 32.2% below its 52-week high. Over the past week it ranged between $22.24 and $27.57.

Past 12 Months
+15.2%
-16.0%
-8.3%
-7.6%
-7.6%
-7.6%
1W +$3.59
1M -$5.20
3M -$2.48
6M -$2.24
YTD -$2.24
1Y -$2.24

AVLN was -7.6% over the past year, -7.6% over six months, -7.6% year to date, +15.2% in the last week.

12 Months vs Market
AVLN
-7.6%
DIA
+13.3%
SPY
+14.4%
QQQ
+16.3%
IWM
+13.7%

Over the past 12 months AVLN returned -7.6% versus DIA (Dow) +13.3%, SPY (S&P 500) +14.4%, QQQ (Nasdaq 100) +16.3% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 1.19× 3-mo avg
Today 286,745 3-mo avg 240.9K
1W
237.1K
1M
307.0K
3M
240.9K
6M
364.7K
YTD
364.7K
1Y
364.7K

AVLN most recently traded 286,745 shares against a 3-month average daily volume of 240.9K.

More News

Read More
News headline image
Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
September 08, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis
September 08, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026
August 24, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 12, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis
June 17, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead ↗
June 05, 2026
Via MarketBeat
Topics Initial Public Offering
News headline image
Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights
June 03, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn to Participate in the Jefferies Global Healthcare Conference
May 27, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn Announces Additional Long-term Data on AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis to be Presented at the European Alliance of Associations for Rheumatology 2026
May 21, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn to Present Patient-Centered Research on AP01 Delivery and Supportive Care Experiences at American Thoracic Society 2026 International Conference
May 05, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Avalyn Pharma Inc. - common stock publicly traded?
Yes, Avalyn Pharma Inc. - common stock is publicly traded.
What exchange does Avalyn Pharma Inc. - common stock trade on?
Avalyn Pharma Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Avalyn Pharma Inc. - common stock?
The ticker symbol for Avalyn Pharma Inc. - common stock is AVLN on the Nasdaq Stock Market
What is the current price of Avalyn Pharma Inc. - common stock?
The current price of Avalyn Pharma Inc. - common stock is 27.25
When was Avalyn Pharma Inc. - common stock last traded?
The last trade of Avalyn Pharma Inc. - common stock was at 10/22/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap